Skip to content

Enterprise value at other companies

Abbott logo
AbbottABT
$205.65B-13.1%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$58.42B-29.4%
TFX
TeleflexTFX
$7.74B-2.0%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$622.06B+50.5%
Stryker logo
StrykerSYK
$137.35B-12.4%
Boston Scientific logo
Boston ScientificBSX
$141.04B-1.0%

Other financials

Income statement

See full
Revenue$381.9M+7.5%
Gross profit$184.8M+7.4%
Operating income$44.2M+7.6%
Net income$41.0M+36.0%
EPS (diluted)$0.68+38.8%

Balance sheet

See full
Cash & equivalents$488.1M+23.4%
Total debt$821.6M+0.5%
Total equity$1.6B+13.9%
Total assets$2.7B+10.2%

Cash flow

See full
Operating cash flow$40.7M+0.3%
CapEx$16.0M-24.0%
Free cash flow$24.7M+26.5%

Valuation

See full
Market cap$4.01B-34.1%
P/E28.8×-21.0×
P/S2.6×-1.8×

Profitability

See full
Gross margin48.7%+0.9pp
Operating margin12.2%+0.6pp
Net margin9%+0.2pp
FCF margin14.3%+1.3pp

Returns & leverage

See full
Return on equity9.1%0.0pp
Debt / equity0.5×-0.1×
Current ratio5.1×+0.2×

Where this comes from

Calculated from Merit Medical Systems’s reported figures.

The official record: Merit Medical Systems’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merit Medical Systems's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merit Medical Systems's enterprise value?
Merit Medical Systems (MMSI) reported enterprise value of $4.43B in Q1 2026.
How has Merit Medical Systems's enterprise value changed year-over-year?
Merit Medical Systems's enterprise value decreased by 33.3% year-over-year, from $6.64B to $4.43B.
What is the long-term trend for Merit Medical Systems's enterprise value?
Over 5 years (2020 to 2025), Merit Medical Systems's enterprise value has grown at a 9.8% compound annual growth rate (CAGR), from $3.51B to $5.6B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.